A physician affiliated with public health watchdog group Public Citizen released a statement on Dec. 6, 2011, regarding his removal from the U.S. Food and Drug Administration advisory committee meeting to discuss the risk of blood clots from the Yasmin line of birth control pills.
Dr. Sidney Wolfe M.D., is director of Public Citizen’s Health Research Group. He was originally supposed to be ...
continue reading...
A story in U.S. News and World Report says new research suggests the best way for Type 2 diabetes patients to expand their life spans is to avoid kidney disease.
Researchers from the University of Washington in Seattle found that 10-year mortality rates for people with both type 2 diabetes and kidney disease is more than 31 percent.
That number dropped to 12 percent for people with only type 2 diabetes. And ...
continue reading...
An orthopedic surgeon testifying at a trial over Johnson & Johnson’s ASR hip implants described tissue colored black with metal debris around the hip joint as the “signature injury” of the devices.
According to a story in the Newark Star Ledger, Dr. Craig Swenson of La Jolla, Calif., refers to the blackened tissue around the artificial hip joints as the “black hole.”
The trial in Los Angeles is the first of 10,000 ...
continue reading...Johnson & Johnson’s earnings for the fourth quarter were better than expected, despite $800 million in expenses related to the company’s recall of its all-metal hip implant.
According to a story in Reuters, the company earned $1.19 per share, excluding one-time items, in the fourth quarter. That beat analysts’ average estimate of $1.17.
The story says the company faces about 2,000 lawsuits related to the “metal-on-metal” hip implant manufactured by Johnson & ...
continue reading...
A 2011 internal report from Johnson & Johnson concluded that the company’s metal-on-metal hip implants would fail within five years in nearly 40 percent of patients, requiring them to undergo painful and costly replacement procedures.
A story in the New York Times says Johnson & Johnson recalled the device, made by subsidiary DePuy Orthopaedics, in 2010. Yet even as the company ...
continue reading...The owners of a specialty pharmacy blamed for a deadly fungal meningitis outbreak got more than $16 million from the business last year – which accounts for about half of its sales.
The Boston Globe, citing bankruptcy records, reports that four family members who co-founded the New England Compounding Center also ran up expenses on corporate American Express cards totaling $90,000, including charges made after the company shut down in October.
The federal Centers for Disease Control and ...
continue reading...
